Clinical Trials Browser

Phase 2 × Cardiotoxicity × dapagliflozin × Clear all

NCT06888505 2025-09-18

DAPA-AIC

Phase 2 Completed

Cardiotoxicity

NCT06341842 2024-04-02

PROTECT

Phase 2 Unknown

Breast Neoplasms, Cardiotoxicity